Detalhe da pesquisa
1.
Treatment of high-risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes.
Pediatr Blood Cancer
; 71(2): e30792, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38053237
2.
Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group.
Lancet Oncol
; 12(8): 719-20, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21719348